Related Experiment Videos

Release of LPL activity after intravenous injection of a low molecular weight heparin

J Etienne, F Millot, R Pieron

British Journal of Clinical Pharmacology

|December 1, 1983

Abstract:

A low molecular weight heparin (MW 4000-6000), PK 10169 (Pharmuka), with much reduced anticoagulant in vitro capacity, retains the properties of the standard heparin in releasing lipoprotein lipase and hepatic lipase activity after being injected intravenously.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: Results of EORTC Children Leukemia Group study 58951.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2021

Investigation of primary immune deficiency after severe bacterial infection in children: A population-based study in western France.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2021

Expert judgment based multicriteria decision models to assess the risk of pesticides on reproduction failures of grey partridge.

SAR and QSAR in environmental research·2017

Combined therapy in children and adolescents with classical Hodgkin's lymphoma: A report from the SFCE on MDH-03 national guidelines.

Pediatric hematology and oncology·2016

Prediction of the endocrine disruption profile of pesticides.

SAR and QSAR in environmental research·2015

IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.

Leukemia·2015

See all related articles